Enzychem Lifesciences Corporation (KOSDAQ:183490)

Enzychem Lifesciences Revenue

Enzychem Lifesciences had revenue of 17.01B KRW in the quarter ending September 30, 2024, a decrease of -13.93%. This brings the company's revenue in the last twelve months to 82.07B, up 37.99% year-over-year. In the year 2023, Enzychem Lifesciences had annual revenue of 76.04B with 185.46% growth.

• Revenue (ttm): 82.07B
• Revenue Growth: +37.99%
• P/S Ratio: 1.34
• Revenue / Employee: 672.72M
• Employees: 122
• Market Cap: 105.23B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	76.04B	49.40B	185.46%
Dec 31, 2022	26.64B	3.66B	15.94%
Dec 31, 2021	22.98B	-2.84B	-11.01%
Dec 31, 2020	25.82B	-5.65B	-17.96%
Dec 31, 2019	31.47B	434.68M	1.40%